This HTML5 document contains 34 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03483/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03483/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03483/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03483/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03483
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03483 n12:DB03483
dcterms:title
4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid
adms:identifier
n8:10033310 n9:46508067 n10:DB03483 n11:BGD
n3:IUPAC-Name
n4:271B4C96-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C9C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C9B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C98-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C99-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C9A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C94-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C92-363D-11E5-9242-09173F13E4C5 n4:271B4C95-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C93-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4CA2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4CA3-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C9D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C9E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4CA0-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C9F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4CA1-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4CA7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4CA9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4CAA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4CA6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4CA5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4CA8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C97-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4CA4-363D-11E5-9242-09173F13E4C5